|
1
|
Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.
|
Hum Mol Genet
|
2001
|
1.57
|
|
2
|
The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains.
|
Virology
|
2001
|
1.30
|
|
3
|
A gene responsible for autosomal dominant auditory neuropathy (AUNA1) maps to 13q14-21.
|
J Med Genet
|
2004
|
1.02
|
|
4
|
Presence of human papillomavirus predicts recurrence of inverted papilloma.
|
Otolaryngol Head Neck Surg
|
1995
|
0.96
|
|
5
|
Human papillomavirus types important in progression of inverted papilloma.
|
Otolaryngol Head Neck Surg
|
1995
|
0.94
|
|
6
|
Pediatric myofibromatosis of the head and neck.
|
Arch Otolaryngol Head Neck Surg
|
1999
|
0.93
|
|
7
|
DFNA25, a novel locus for dominant nonsyndromic hereditary hearing impairment, maps to 12q21-24.
|
Am J Hum Genet
|
2000
|
0.89
|
|
8
|
The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is important for transactivation.
|
J Gen Virol
|
2001
|
0.85
|
|
9
|
Interpretation of linkage data for a Huntington-like disorder mapping to 4p15.3.
|
Am J Hum Genet
|
2000
|
0.79
|
|
10
|
A gene for autosomal dominant hearing impairment (DFNA14) maps to a region on chromosome 4p16.3 that does not overlap the DFNA6 locus.
|
J Med Genet
|
1999
|
0.79
|
|
11
|
Outcome of newborn hearing screening by ABR compared with four different DPOAE pass criteria.
|
Am J Audiol
|
2000
|
0.78
|
|
12
|
Substituting a telephone call for pediatric adenotonsillectomy postoperative visits.
|
Arch Otolaryngol Head Neck Surg
|
2001
|
0.75
|
|
13
|
Evidence in support of a different model of universal newborn hearing loss identification.
|
Am J Audiol
|
2001
|
0.75
|
|
14
|
No association between DFNA6 and Pro250Arg mutation in FGFR3.
|
Am J Med Genet
|
1999
|
0.75
|
|
15
|
Characterization of autosomal dominant non-syndromic hearing loss loci: DFNA 4, 6, 10 and 13.
|
Adv Otorhinolaryngol
|
2000
|
0.75
|